It activates both GLP-1 and GIP receptors, which are involved in appetite regulation, blood sugar management, and metabolic function
doi: 10.1017/S0007114510002874 89 MobiniRTremaroliVStahlmanMKarlssonFLevinMLjungbergMet al
Formichi C, Baronti W, de Gennaro G, Cerrai Ceroni M, Nigi L, Rizzo L, et al
Month 4 (1.7 mg): Weight loss tends to continue at a steady pace for most patients
Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial
Research highlights include: Long-Term Efficacy : Studies indicate that GLP-1 medications remain effective for weight loss over extended periods, with sustained reductions in body weight and improvements in glycemic control